Evidence map›Paper›PMID 36602372›Full record

ArticleAntimicrobial agents and chemotherapy2023

Andrés Blanco-Di Matteo, Nuria Garcia-Fernandez, Aitziber Aguinaga Pérez, Francisco Carmona-Torre, Amaya C Oteiza, José Leiva, José Luis Del Pozo

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Strategies to Prevent Hemodialysis Catheter Dysfunction.Journal of the American Society of Nephrology : JASN · 2025
    Review
  4. Article
  5. Review
  6. Frontiers in medicine · 2025
    Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Andrés Blanco-Di MatteoInfectious Diseases Division, Clinica Universidad de Navarra, Pamplona, Spain.
Nuria Garcia-FernandezNephrology Department, Clinica Universidad de Navarra, Pamplona, Spain.
Aitziber Aguinaga PérezClinical Microbiology Department, Hospital Universitario de Navarra, Pamplona, Spain.
Francisco Carmona-TorreInfectious Diseases Division, Clinica Universidad de Navarra, Pamplona, Spain.
Amaya C OteizaClinical Microbiology Department, Clínica Universidad de Navarra, Pamplona, Spain.
José LeivaClinical Microbiology Department, Clínica Universidad de Navarra, Pamplona, Spain.
José Luis Del PozoInfectious Diseases Division, Clinica Universidad de Navarra, Pamplona, Spain.
Clinica Universidad de Navarra · ESNavarre Institute of Health Research · ESUniversidad de Navarra · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tunneled central venous catheter (TCVC) related infection remains a challenge in the care of hemodialysis patients. We aimed to determine the best antimicrobial lock therapy (ALT) to eradicate coagulase-negative staphylococci (CoNS) biofilms. We studied the colonization status of the catheter every 30 days by quantitative blood cultures (QBC) drawn through all catheter lumens. Those patients with a significant culture (i.e.,100 to 1,000 CFU/mL) of a CoNS were classified as patients with a high risk of developing catheter-related bloodstream infections (CRBSI). They were assigned to receive daptomycin, vancomycin, teicoplanin lock solution, or the standard of care (SoC) (i.e., heparin lock). The primary endpoint was to compare eradication ability (i.e., negative QBC for 30 days after ending ALT) rates between different locks and the SoC. A second objective was to analyze the correlation between ALT exposure and isolation of CoNS with antimicrobial resistance. Daptomycin lock was associated with a significant higher eradication success than with the SoC: 85% versus 30% (relative risk [RR] = 14, 95% confidence interval [CI] = 2.4 - 82.7); followed by teicoplanin locks with a 83.3% success (RR = 11.7; 95% CI = 2 - 70.2). We observed CoNs isolates with a higher teicoplanin MIC in patients with repeated teicoplanin locks exposure (coefficient = 0.3; 95% CI = 0.11 - 0.47). However, teicoplanin MICs decreased in patients treated with vancomycin locks (coefficient = -0.56; 95% CI = -0.85 - -0.02). Methicillin-resistance decreased with accumulative ALT (RR = 0.82; 95% CI = 0.69 - 0.98). In this study, daptomycin locks achieve the highest eradication rate of CoNS from hemodialysis catheters

Indexed as

Anti-Infective AgentsCatheter-Related InfectionsCentral Venous CathetersDaptomycinAnti-Bacterial AgentsBiofilmsCoagulaseHumansStaphylococcusTeicoplaninVancomycinAnti-Bacterial AgentsAnti-Infective AgentsCoagulaseDaptomycinTeicoplaninVancomycinbiofilmcatheter-related bloodstream infectioncoagulase-negative staphylococcihemodialysistunneled central venous catheter

Identifiers

PMID36602372
PMCPMC9872714
OpenAlexW4313544939

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.